Please login to the form below
Precision medicine
This page shows the latest Precision medicine news and features for those working in and with pharma, biotech and healthcare.
FDA approves Novartis’ Pluvicto for prostate cancer
Although the treatment landscape for mCRPC continues to evolve, there is a high unmet need for additional precision medicine treatment options to improve outcomes for these patients,” said Jamie Bearse, CEO
Latest news
-
Green light for Amgen’s KRAS inhibitor in the UK
This medicine expands our list of effective precision therapies in lung cancer that are helping to improve survival for patients with limited options.”.
-
UK’s Competition and Markets Authority to review AZ/Alexion merger
The Anglo-Swedish pharma company hopes to combine its own precision medicine expertise with Alexion’s specialist rare disease knowledge to leverage its capabilities in a number of therapy areas, including
-
Novartis bolsters radioligand therapy pipeline with new licence agreement
Radioligand therapies are a new potential class of precision oncology drugs. ... Radioligand therapies have emerged as a new potential class of precision oncology drugs.
-
Positive late-stage results for Novartis’ radioligand therapy in advanced prostate cancer
177Lu-PSMA-617 is a type of precision medicine that combines a targeting compound – ligand – and a therapeutic radioisotope. ... This groundbreaking data confirms our belief in the potential of 177Lu-PSMA-617 to reimagine outcomes for these patients
-
Servier to acquire Agios’ oncology business in $1.8bn deal
area. “The strategic acquisition of Agios’ oncology business, including its precision medicine portfolio and pipeline, is aligned with our ambition to become a recognised player in oncology and further supports our
More from news
Approximately 3 fully matching, plus 43 partially matching documents found.
Latest Intelligence
-
Medical Affairs: centre-stage in scientific engagement strategies
There are myriad drivers of Medical Affairs’ strategic renaissance – increased complexity of technologies and therapeutics being developed to address disease pathophysiology, the rise of precision medicine as a standard of care, ... A deep knowledge
-
How early-stage clinical research is facilitating the new wave of personalised medicines
By Jorg Taubel. The transformative potential of personalised medicine in improving health outcomes has been well documented. ... Lessons learned and building on successful gene therapy studies. The development of early-phase precision medicine studies is
-
The promise of precision medicine
We hope to have trained around 700 precision medicine professionals within the next five years. ... This is especially important in precision medicine, where research and understanding are constantly evolving.
-
Unlocking the potential of precision medicine in oncology
Joaquín Casariego García-Lubén. Precision medicine is a term we are all familiar with in the industry, however its true meaning should not be underestimated. ... Pushing the boundaries. Janssen’s precision medicine research, supplemented by new
-
Staying ahead in the era of precision medicine
Precision medicine: the potential is huge. The potential for precision medicine is evident. ... What’s next for the McCann Health Global Scientific Council in precision medicine?
More from intelligence
Approximately 6 fully matching, plus 20 partially matching documents found.
Latest appointments
-
Agios appoints Celgene’s Jackie Fouse
to launch its first precision medicine.
-
Global Gene Corp appoints new chief data and technology officer
and thought leadership in the domain of genomics and precision medicine.
-
AZ's Mene Pangalos joins Precision Medicine Catapult board
Pangalos will join the board of the Precision Medicine Catapult, the newly established centre in Cambridge designed to shape the future of precision medicine in the UK. ... In his role as non-executive director, Pangalos will provide a pharmaceutical
-
AstraZeneca appoints Sean Bohen as chief medical officer
His extensive diagnostics experience will also reinforce our efforts in precision medicine.”. ... Before joining Genentech he was a clinical instructor in oncology at Stanford University School of Medicine, a research associate at the Howard Hughes
-
Sophia Genetics names Marylin Mermod Schule as CFO
Mermod Schule joins the firm, which specialises in data driven medicine, from Benjamin de Rothschild Bank where she held the role of deputy director. ... The growth of precision medicine and increasing public interest in the value of genetic testing mean
More from appointments
Approximately 0 fully matching, plus 8 partially matching documents found.
Latest from PMHub
-
6 trends shaping the future of personalized medicine
With precision medicines accounting for at least 25% of FDA approvals in the last 7 years, personalized healthcare is far from niche. ... This is just what the Personalized Medicine Coalition did at its 16th annual conference, “From an Enterprise
-
Disrupting Cell Engineering with Non-Viral Modalities
Jessica Schwaber, Scientific Director, Cell &Gene Therapy, Avectas, explores her company’s unique cell engineering platform, the recent shift in cell &gene therapy commercial needs, current barriers to realizing the full potential of cell &gene
-
Advancing Drug Discovery with Structured and Intelligent Data
uncovering of patient insights, precision medicine, and much more.
-
Why you should feel optimistic about the future of healthcare
Precision medicine. Precision medicine takes into account a person’s individual genetics, environment and lifestyle to match them to a treatment that will give them the best possible outcomes. ... Precision medicines already exist; imatinib works to
-
Quantum Computing, Artificial Intelligence, & Machine Learning for Drug Discovery
Dr. Shahar Keinan, Co-founder &CEO of POLARIS Quantum Biotech, explores quantum computing and AI for drug discovery, the Quantum Molecular Design process, and how POLARISqb is working to improve precision ... medicine and find cures for all known diseases
More from PMHub
Approximately 27 fully matching, plus 17 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- Vice President, Medical Communications, UK, six figure package
-
Six figure salary
- Bristol Myers Squibb announces positive trial results for treatment of MS
- Biogen and Happify Health team up to create digital platform for MS patients
- Moderna to launch Innovation and Technology Center in the UK
- Enanta takes legal action against Pfizer over Paxlovid patent infringement
- Novartis and Precision BioSciences announce in vivo gene editing collaboration
- Pfizer and BioNTech share positive results for Omicron-adapted COVID-19 vaccine
- Why project managers are key to creating quality content
- Pfizer and BioNTech sign $3.2bn COVID-19 vaccine supply agreement with US government
- EMA grants Bavarian Nordic access to PRIME scheme for RSV vaccine candidate
- Eli Lilly to supply US government with 150,000 additional doses of bebtelovimab
- NICE issues final appraisal recommending LEO Pharma’s Adtralza for moderate-to-severe atopic dermatitis
- How Resonant’s innovation and creativity resolve healthcare communications challenges
- ALL SYSTEMS GO: UNDERSTANDING WHO’S WHO IN THE NEW NHS LANDSCAPE
- A creative awakening – how pharma is bringing innovation to the patient journey
- AstraZeneca’s Evusheld phase 3 results show high level of protection against COVID-19
- Innovative Health Initiative launches first two calls for proposals to tackle ‘biggest’ health research challenges
- Novartis endorses Kigali Declaration by investing $250m for tropical diseases
- Pfizer, Mylan move ahead with generics merger and spin-out
PMHub
Hamell
Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...
Latest intelligence
- Our Top 5 Pharma Picks From Cannes Lions
- Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
- The Evolving Role of the Sales Rep
- The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
- Measure your omnichannel maturity with our new tool
- Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....
